Laszlo, G. S., Beddoe, M. E., Godwin, C. D., Bates, O. M., Gudgeon, C. J., Harrington, K. H., & Walter, R. B. (2019). Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330. Haematologica.
シカゴスタイル引用形Laszlo, George S., Mary E. Beddoe, Colin D. Godwin, Olivia M. Bates, Chelsea J. Gudgeon, Kimberly H. Harrington, , Roland B. Walter. "Relationship between CD33 Expression, Splicing Polymorphism, and in Vitro Cytotoxicity of Gemtuzumab Ozogamicin and the CD33/CD3 BiTE® AMG 330." Haematologica 2019.
MLA引用形式Laszlo, George S., et al. "Relationship between CD33 Expression, Splicing Polymorphism, and in Vitro Cytotoxicity of Gemtuzumab Ozogamicin and the CD33/CD3 BiTE® AMG 330." Haematologica 2019.